FDA.reportPublic FDA data

POLYETHYLENE GLYCOL 6000

Substance profile for UNII 30IQX730WE, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
30IQX730WE
Preferred term
POLYETHYLENE GLYCOL 6000
Registry number
25322-68-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1314384
PubChem
0
NCIt
C84085
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1314384https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1314384
NCI ThesaurusC84085https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C84085
FDA Substance Registration System30IQX730WEhttps://precision.fda.gov/uniisearch/srs/unii/30IQX730WE

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEAMOXICILLIN AND CLAVULANATE POTASSIUM1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use levofloxacin tablets safely and effectively. See full prescribing information for levofloxacin tablets. LEVOFLOXACIN tablets, for oral use Initial U.S. Approval: 19968
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets . Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 19921
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WENABUMETONE2
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WERx only4
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WERx only2
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEBisoprolol Fumarate and Hydrochlorothiazide Tablets USP1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEMetformin Hydrochloride Tablets USP1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEZinc Oxide Ointment7
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use clopidogrel bisulfate safely and effectively. See full prescribing information for clopidogrel tablets, USP. CLOPIDOGREL Tablets USP, for oral use Initial U.S. Approval: 19974
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEZinc Oxide Ointment12
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use donepezil hydrochloride safely and effectively. See full prescribing information for donepezil hydrochloride tablets. Donepezil hydrochloride tablets USP, film coated for oral use Initial U.S. Approval: 19961
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use Escitalopram Tablets USP safely and effectively. See full prescribing information for Escitalopram Tablets USP. Initial U.S. Approval: 20025
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEMetformin Hydrochloride Tablets, USP2
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEParoxetine Tablets, USP1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets . Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 19921
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets. Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 19923
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use clopidogrel bisulfate safely and effectively. See full prescribing information for clopidogrel tablets, USP. CLOPIDOGREL Tablets USP, for oral use Initial U.S. Approval: 19971
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEBisoprolol Fumarate and Hydrochlorothiazide Tablets USP2
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEFACTIVE ® (gemifloxacin mesylate) Tablets1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEParoxetine Tablets, USP1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use clopidogrel bisulfate safely and effectively. See full prescribing information for clopidogrel tablets, USP. Clopidogrel Tablets, USP Initial U.S. Approval: 19971
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WESohMed™ Pain Relief PM1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WESohMed™ Sinus1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WESohMed™ Allergy1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WESohMed™ Cold Relief1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WESohMed™ Allergy Sinus1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WESohMed™ Extra Strength1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEGalshield Zinc Oxide / Dimethicone1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEGalentic GalShield Ointment1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEDrug Facts4
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use metoprolol succinate extended-release tablets safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets. Metoprolol Succinate Extended-Release Tablets, USP for Oral Use INITIAL U.S. APPROVAL: 19925
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEDrug Facts1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEDrug Facts1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEConRx™ Allergy Sinus1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEConRx™ Cold1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEConRx™ Alert1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEConRx™ Allergy1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEConRx™ Extra Strength1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEConRx™ pain Reliever1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEConRx™ PM1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEConRx™ Sinus1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEf3c500b9-1fdd-4382-921d-b333d92d34e72
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use clopidogrel safely and effectively. See full prescribing information for clopidogrel. Clopidogrel Tablets, USP Initial U.S. Approval: 19972
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEParoxetine Tablets, USP1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WE4aad770b-a342-45c5-8199-21a1240603141
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEConRx Allergy Sinus Multi-Symptoms1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEConRx Cold1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEConRx Sinus1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use lansoprazole safely and effectively. See full prescribing information for: Lansoprazole Delayed-Release Capsules, USP For oral administration Initial U.S. Approval: 19951
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use KEPPRA ® safely and effectively. See full prescribing information for KEPPRA. KEPPRA (levetiracetam) tablets, for oral use KEPPRA (levetiracetam) oral solution Initial U.S. Approval: 19993
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 20012
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEATOPALM Oral Pain Relief Gel1
polyethylene glycol 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX. PLAVIX (clopidogrel bisulfate) tablets Initial U.S. Approval: 19973
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use donepezil hydrochloride tablets safely and effectively. See full prescribing information for donepezil hydrochloride tablets. Donepezil Hydrochloride Tablets Rx Only Initial U.S. Approval: 19961
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEb4db7cdc-bcad-4825-9840-6c36246c6d314
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEBisoprolol Fumarate Tablets USP2
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEPrilosec OTC ® omeprazole magnesium delayed- release tablets 20.6 mg / acid reducer1
Polyethylene Glycol 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use Fenoglide ® safely and effectively. See full prescribing information for Fenoglide. Fenoglide (fenofibrate) Tablets Initial U.S. Approval: 19932
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WE7b1d9124-5fde-4f57-9fca-ee061750fcc31
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEDrug Fact1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEOCELLA ™ 28 TABLETS (drospirenone and ethinyl estradiol)2
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEGlytone Retexturize Body2
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEDrug Facts1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets, USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets, USP. Pantoprazole Sodium Delayed-Release Tablets, USP Initial U.S. approval: 20002
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEParoxetine Tablets, USP1
polyethylene glycol 6000INACTIVE INGREDIENT30IQX730WEKEPPRA ® (levetiracetam) 250 mg, 500 mg, 750 mg, and 1000 mg tablets 100 mg/mL oral solution1
polyethylene glycol 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX. PLAVIX (clopidogrel bisulfate) tablets Initial U.S. Approval: 19971
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEBisoprolol Fumarate Tablets USP1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use BONIVA Tablets safely and effectively. See full prescribing information for BONIVA Tablets. BONIVA® (ibandronate sodium) Tablets Initial U.S. Approval: 20031
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use Natazia safely and effectively. See full prescribing information for Natazia. Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for oral use Initial U.S. Approval: 20101
polyethylene glycol 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX. PLAVIX (clopidogrel bisulfate) tablets Initial U.S. Approval: 19972
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEPAROXETINE TABLETS USP1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEMetformin Hydrochloride Tablets USP4
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEMetformin Hydrochloride Tablets, USP1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX. PLAVIX (clopidogrel bisulfate) tablets Initial U.S. Approval: 19971
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEThese highlights do not include all the information needed to use FENOGLIDE safely and effectively. See full prescribing information for FENOGLIDE. FENOGLIDE (fenofibrate) tablet for oral use Initial U.S. Approval: 19931
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEBUPROPION HYDROCHLORIDE TABLETS USP Rx only1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEf0b31daa-0792-43d5-af08-8b6a864dc90a1
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WE89245260-c470-4a4c-8ef6-12598dc28e4c2
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEPAROXETINE (PAROXETINE HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3988
polyethylene glycol 6000INACTIVE INGREDIENT30IQX730WEPLAVIX (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3378
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEMETFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3282
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEPAROXETINE (PAROXETINE HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3198
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEONDANSETRON HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3071
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]1002
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEBISOPROLOL FUMARATE TABLET [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEBUPROPION HYDROCHLORIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEFINASTERIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEVALACYCLOVIR TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEMIRTAZAPINE TABLET, FILM COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]379
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEPAROXETINE (PAROXETINE HYDROCHLORIDE) TABLET [INTERNATIONAL LABORATORIES, INC.]27
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WELIALDA (MESALAMINE) TABLET, DELAYED RELEASE [SHIRE US MANUFACTURING INC.]26
polyethylene glycol 6000INACTIVE INGREDIENT30IQX730WEBONIVA (IBANDRONATE SODIUM) TABLET, FILM COATED [GENENTECH, INC.]22
polyethylene glycol 6000INACTIVE INGREDIENT30IQX730WEMULTAQ (DRONEDARONE) TABLET, FILM COATED [SANOFI-AVENTIS U.S. LLC]22
polyethylene glycol 6000INACTIVE INGREDIENT30IQX730WEPLAVIX (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [BRISTOL-MYERS SQUIBB/SANOFI PHARMACEUTICALS PARTNERSHIP]20
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEPAROXETINE TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]19
polyethylene glycol 6000INACTIVE INGREDIENT30IQX730WEKEPPRA (LEVETIRACETAM) TABLET, FILM COATED KEPPRA (LEVETIRACETAM) SOLUTION [UCB, INC.]16
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEDYNASHIELD WITH DIMETHICONE (ZINC OXIDE AND DIMETHICONE) CREAM [DYNAREX CORPORATION]14
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEFAMCICLOVIR TABLET, FILM COATED [ACTAVIS PHARMA, INC.]14
polyethylene glycol 6000INACTIVE INGREDIENT30IQX730WEKEPPRA XR (LEVETIRACETAM) TABLET, FILM COATED, EXTENDED RELEASE [UCB, INC.]14
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEPAROXETINE (PAROXETINE HYDROCHLORIDE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]14
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WETOPIRAMATE CAPSULE, COATED PELLETS [TEVA PHARMACEUTICALS USA INC]14
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEFINASTERIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]13
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEMIRTAZAPINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]13
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEAROMASIN (EXEMESTANE) TABLET [PHARMACIA AND UPJOHN COMPANY]12
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEESCITALOPRAM TABLET, FILM COATED [INTERNATIONAL LABS, INC.]12
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEONDANSETRON HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]12
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEVALACYCLOVIR TABLET, FILM COATED [RANBAXY PHARMACEUTICALS INC.]12
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEDOXYCYCLINE TABLET [HERITAGE PHARMACEUTICALS INC.]11
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEMETFORMIN HYDROCHLORIDE TABLET, FILM COATED [ASCEND LABORATORIES, LLC]11
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEULTRAMICROSIZE GRISEOFULVIN (ULTRAMICROSIZE GRISEOFULVIN TABLETS) TABLET, COATED [COREPHARMA, LLC]11
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEDESVENLAFAXINE TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]10
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEMOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA]10
polyethylene glycol 6000INACTIVE INGREDIENT30IQX730WEPLAVIX (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]10
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEROPINIROLE 2 MG (ROPINIROLE) TABLET, FILM COATED, EXTENDED RELEASE ROPINIROLE 4 MG (ROPINIROLE) TABLET, FILM COATED, EXTENDED RELEASE ROPINIROLE 6 MG (ROPINIROLE) TABLET, FILM COATED, EXTENDED RELEASE ROPINIROLE 8 MG (ROPINIROLE) TABLET, FILM COATED, EXTENDED RELEASE ROPINIROLE 12 MG (ROPINIROLE) TABLET, FILM COATED, EXTENDED RELEASE [TRIGEN LABORATORIES, INC.]10
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WETROSPIUM CHLORIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA]10
POLYETHYLENE GLYCOL 6000INACTIVE INGREDIENT30IQX730WEYASMIN (DROSPIRENONE AND ETHINYL ESTRADIOL) KIT [BAYER HEALTHCARE PHARMACEUTICALS INC.]10